Dowling Joseph D 4
4 · CV Sciences, Inc. · Filed Apr 1, 2022
Insider Transaction Report
Form 4
Dowling Joseph D
DirectorChief Executive Officer
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−600,000→ 0 totalExercise: $0.38Exp: 2024-09-30→ Common Stock (600,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−1,500,000→ 0 totalExercise: $0.33Exp: 2030-03-19→ Common Stock (1,500,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−200,000→ 0 totalExercise: $0.73Exp: 2015-09-22→ Common Stock (200,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−1,500,000→ 0 totalExercise: $0.59Exp: 2031-03-08→ Common Stock (1,500,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−500,000→ 0 totalExercise: $0.66Exp: 2029-02-19→ Common Stock (500,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−500,000→ 0 totalExercise: $0.40From: 2018-03-20Exp: 2028-03-19→ Common Stock (500,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−100,000→ 0 totalExercise: $0.38Exp: 2025-05-20→ Common Stock (100,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−100,000→ 0 totalExercise: $0.38Exp: 2027-03-14→ Common Stock (100,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−1,000,000→ 0 totalExercise: $0.37Exp: 2026-07-05→ Common Stock (1,000,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2022-03-30−1,000,000→ 0 totalExercise: $0.36Exp: 2027-04-06→ Common Stock (1,000,000 underlying)
Footnotes (6)
- [F1]The option is durational based. All option shares were vested and exercisable on the date of cancellation.
- [F2]On March 30, 2022, the stock options were cancelled by mutual agreement of the reporting person and the issuer. The reporting person received an aggregate of $100 as consideration for the cancellation.
- [F3]The option is durational based. 750,000 option shares were vested and exercisable on the date of cancellation. Twenty-five (25%) of the option shares were scheduled to vest and become exercisable on September 1, 2022 and March 1, 2023, provided, that there was no termination of service as of such date.
- [F4]The option was fully vested on the date of grant.
- [F5]The option is performance-based. 500,000 option shares were vested and exercisable on the date of cancellation. The remaining option shares were scheduled to vest and become exercisable in accordance with certain performance criteria which were not met at the date of cancellation.
- [F6]The option is performance-based. 250,000 option shares were vested and exercisable on the date of cancellation. The remaining option shares were scheduled to vest and become exercisable in accordance with certain performance criteria which were not met at the date of cancellation.